Service de Neurochirurgie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Centre d'Evaluation Et Traitement de La Douleur (CETD), Hôpitaux Universitaires de Strasbourg, 1 Avenue Molière, 67200, Strasbourg, France.
Trials. 2023 Jun 19;24(1):418. doi: 10.1186/s13063-023-07420-y.
The prevalence of post-surgical lumbar neuropathic radiculopathy is approximately 30%. Poor response to the recommended treatments for neuropathic pain, namely antidepressants and/or gabapentinoids, requires the development of new techniques to prevent chronic pain. One such well-tolerated technique is the administration of autologous plasma enriched in platelets and fibrin (PRF). This approach is largely used in regenerative medicine owing to the anti-inflammatory and analgesic properties of PRF. It could also be an interesting adjuvant to surgery, as it reduces neurogenic inflammation and promotes nerve recovery, thereby reducing the incidence of residual postoperative chronic pain. The aim of the present study is to evaluate the benefit of periradicular intraoperative application of PRF on the residual postsurgical neuropathic pain after disc herniation surgery.
A randomized, prospective, interventional, controlled, single-blind study with evaluation by a blind outcome assessor will be performed in Strasbourg University Hospital. We will compare a control group undergoing conventional surgery to an experimental group undergoing surgery and periradicular administration of PRF (30 patients in each arm). The primary outcome is the intensity of postoperative neuropathic radicular pain, measured by a visual analog scale (VAS) at 6 months post-surgery. The secondary outcomes are the characteristics of neuropathic pain (NPSI), the quality of life (SF-12 and PGIC), the presence of anxiety/depression symptoms (HAD), and the consumption of analgesics. We will also carry out transcriptomic analysis of a panel of pro- and anti-inflammatory cytokines in blood samples, before surgery and at 6 months follow-up. These gene expression results will be correlated with clinical data, in particular, with the apparition of postoperative neuropathic pain.
This study is the first randomized controlled trial to assess the efficacy of PRF in the prevention of neuropathic pain following surgery for herniated disc. This study addresses not only a clinical question but will also provide information on the physiopathological mechanisms of neuropathic pain.
This study is registered at ClinicalTrials.gov: NCT05196503 , February 24, 2022.
术后腰椎神经根病的患病率约为 30%。对于神经病理性疼痛的推荐治疗方法(即抗抑郁药和/或加巴喷丁类药物)反应不佳,需要开发新的技术来预防慢性疼痛。一种耐受良好的技术是使用富含血小板和纤维蛋白的自体血浆(PRF)进行治疗。由于 PRF 具有抗炎和镇痛特性,因此这种方法在再生医学中得到了广泛应用。它也可能是手术的一种有趣的辅助手段,因为它可以减少神经源性炎症并促进神经恢复,从而降低术后残留慢性疼痛的发生率。本研究的目的是评估椎间盘突出症手术后在神经根周围术中应用 PRF 对残留术后神经病理性疼痛的益处。
在斯特拉斯堡大学医院将进行一项随机、前瞻性、干预性、对照、单盲研究,由盲法结局评估者进行评估。我们将比较接受常规手术的对照组和接受手术加 PRF 神经根周围给药的实验组(每组 30 例)。主要结局是术后神经病理性根痛的强度,通过术后 6 个月的视觉模拟量表(VAS)进行测量。次要结局是神经病理性疼痛的特征(NPSI)、生活质量(SF-12 和 PGIC)、焦虑/抑郁症状的存在(HAD)和镇痛药的消耗。我们还将在术前和 6 个月随访时对血液样本中一组促炎和抗炎细胞因子进行转录组分析。这些基因表达结果将与临床数据相关联,特别是与术后神经病理性疼痛的出现相关联。
本研究是第一项评估 PRF 在预防椎间盘突出症手术后神经病理性疼痛中的疗效的随机对照试验。这项研究不仅解决了一个临床问题,还提供了关于神经病理性疼痛病理生理机制的信息。
本研究在 ClinicalTrials.gov 注册:NCT05196503,2022 年 2 月 24 日。